Veracyte Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
21,884.00
38,190.00
49,503.00
65,085.00
71,953.00
92,008
Cost of Goods Sold (COGS) incl. D&A
13,013.00
17,104.00
22,297.00
26,529.00
31,370.00
36,198
Gross Income
8,871.00
21,086.00
27,206.00
38,556.00
40,583.00
55,810
SG&A Expense
32,044.00
48,392.00
60,672.00
67,359.00
67,121.00
78,043
EBIT
23,173.00
27,306.00
-
28,803.00
26,538.00
22,233
Unusual Expense
2,156.00
3,800.00
-
-
-
-
Non Operating Income/Expense
4,335.00
2,141.00
140.00
202.00
476.00
1,197
Interest Expense
233.00
439.00
378.00
2,757.00
4,941.00
1,963
Pretax Income
25,580.00
29,373.00
33,704.00
31,358.00
31,003.00
22,999
Consolidated Net Income
25,580.00
29,373.00
33,704.00
31,358.00
31,003.00
22,999
Net Income
25,580.00
29,373.00
33,704.00
31,358.00
31,003.00
22,999
Net Income After Extraordinaries
25,580.00
29,373.00
33,704.00
31,358.00
31,003.00
22,999
Net Income Available to Common
25,580.00
29,373.00
33,704.00
31,358.00
31,003.00
22,999
EPS (Basic)
6.15
1.36
1.30
1.09
0.91
0.62
Basic Shares Outstanding
4,158.70
21,639.40
25,994.20
28,830.50
33,925.60
37,020.20
EPS (Diluted)
6.15
1.36
1.30
1.09
0.91
0.62
Diluted Shares Outstanding
4,158.70
21,639.40
25,994.20
28,830.50
33,925.60
37,020.20
EBITDA
22,174.00
26,131.00
31,212.00
25,292.00
22,697.00
18,313
Non-Operating Interest Income
5.00
31.00
-
-
-
-
About Veracyte
View Profile
